LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

Kodu・Aktsiate loetelu・Avita Therapeutics Inc

Avita Therapeutics Inc

Suletud

3.86 -2.53

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

3.82

Max

4.05

Põhinäitajad
By Trading Economics
Sissetulek	1.6M -12M
Müük	554K 18M
Aktsiakasum	-0.536
Kasumimarginaal	-65.968
Töötajad	226
EBITDA	1.6M -9.7M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+58.65% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	7. mai 2026

Turustatistika
By TradingEconomics
Turukapital	-2.5M 121M
Eelmine avamishind	6.39
Eelmine sulgemishind	3.86

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

8.83 / 9.77 Toetus ja vastupanu

Avita Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

26. märts 2026, 23:43 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over Iran Peace Talks -- Market Talk

26. märts 2026, 23:36 UTC

Market Talk

Uudisväärsed sündmused

Gold Rises Amid Signs of Easing Middle East Tensions -- Market Talk

26. märts 2026, 23:35 UTC

Omandamised, ülevõtmised, äriostud

Pernod Ricard: Confirms Discussions With Brown-Forman

26. märts 2026, 23:29 UTC

Tulu

Haier Smart Home: Company to Finance Share Buybacks Via Internal Funds >600690.SH

26. märts 2026, 23:28 UTC

Tulu

Haier Smart Home Plans A Share Buybacks of CNY3.0B-CNY6.0B >600690.SH

26. märts 2026, 23:28 UTC

Tulu

Haier Smart Home Plans to Increase Payout Ratio to 60% for 2027, 2028 >600690.SH

26. märts 2026, 23:28 UTC

Tulu

Haier Smart Home Plans Cash Dividend Payout Ratio of Up to 58% for 2026 >600690.SH

26. märts 2026, 23:27 UTC

Tulu

Haier Smart Home 2025 Net CNY19.55B Vs. Net CNY18.73B >600690.SH

26. märts 2026, 23:27 UTC

Tulu

Haier Smart Home 2025 Rev CNY302.33B Vs. CNY286.01B >600690.SH

26. märts 2026, 23:08 UTC

Market Talk

Infratil's Investor Day Addresses Data-Center Issues -- Market Talk

26. märts 2026, 23:04 UTC

Omandamised, ülevõtmised, äriostud

Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman -- WSJ

26. märts 2026, 23:04 UTC

Omandamised, ülevõtmised, äriostud

Families Behind Pernod, Brown-Forman Would Each Likely Retain Significant Stakes, Source Says -- WSJ

26. märts 2026, 23:04 UTC

Omandamised, ülevõtmised, äriostud

Pernod, Brown-Forman Discussing Mostly Stock Deal, Source Says -- WSJ

26. märts 2026, 23:04 UTC

Omandamised, ülevõtmised, äriostud

Pernod-Brown-Forman Deal Announcement Could Be Weeks Away, Sources Say -- WSJ

26. märts 2026, 23:04 UTC

Omandamised, ülevõtmised, äriostud

Pernod in Deal Talks With Brown-Forman -- WSJ

26. märts 2026, 22:41 UTC

Omandamised, ülevõtmised, äriostud

Brown-Forman: No Agreement Has Been Reached as to Terms of Any Possible Pernod Ricard Transaction

26. märts 2026, 22:41 UTC

Omandamised, ülevõtmised, äriostud

Brown-Forman: Synergies From Contemplated Pernod Ricard Combination Expected to Be Significant

26. märts 2026, 22:26 UTC

Tulu

Jiangxi Copper 2025 Rev CNY544.62B Vs. CNY516.61B >0358.HK

26. märts 2026, 22:26 UTC

Tulu

Jiangxi Copper 2025 Net CNY7.13B Vs. Net CNY6.96B >0358.HK

26. märts 2026, 22:26 UTC

Tulu

Jiangxi Copper Higher Demand For Products Supported Results>0358.HK

26. märts 2026, 22:08 UTC

Tulu

Air China 2025 Loss CNY1.79B Vs. Loss CNY232.56M >0753.HK

26. märts 2026, 22:08 UTC

Tulu

Air China Impairment Loss on Goodwill Weighed on Results>0753.HK

26. märts 2026, 22:08 UTC

Tulu

Air China 2025 Rev CNY171.48B Vs. CNY166.70B >0753.HK

26. märts 2026, 22:07 UTC

Market Talk

Uudisväärsed sündmused

Global Energy Roundup: Market Talk

26. märts 2026, 22:07 UTC

Market Talk

Uudisväärsed sündmused

Open-Pit Gold Miners Most Exposed to High Fuel Prices -- Market Talk

26. märts 2026, 22:00 UTC

Tulu

Tsingtao Brewery 2025 Net CNY4.59B Vs. Net CNY4.34B >0168.HK

26. märts 2026, 22:00 UTC

Tulu

Tsingtao Brewery: Higher Volume Sales of Beer Supported Results>0168.HK

26. märts 2026, 22:00 UTC

Tulu

Tsingtao Brewery 2025 Rev CNY32.47B Vs. CNY32.14B >0168.HK

26. märts 2026, 21:39 UTC

Omandamised, ülevõtmised, äriostud

BlueScope: Sees Early Indications of Strong Interest in Site Adjacent Western Port

26. märts 2026, 21:38 UTC

Omandamised, ülevõtmised, äriostud

BlueScope: Has Begun Expression of Interest Process For 65-Hectare Site Adjacent Western Port

Võrdlus sarnastega

Hinnamuutus

Avita Therapeutics Inc Prognoos

Hinnasiht

By TipRanks

58.65% tõus

12 kuu keskmine prognoos

Keskmine 6.33 USD 58.65%

Kõrge 10 USD

Madal 3.5 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Avita Therapeutics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi Avita Therapeutics Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

8.83 / 9.77Toetus ja vastupanu

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.